- Home
- NLSP vs OZ Comparison
NLSP vs OZ Comparison
Compare NLSP & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- OZ
- Stock Information
- Founded
- NLSP 2015
- OZ 2020
- Country
- NLSP Switzerland
- OZ United States
- Employees
- NLSP N/A
- OZ N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- NLSP Health Care
- OZ
- Exchange
- NLSP Nasdaq
- OZ Nasdaq
- Market Cap
- NLSP 12.4M
- OZ 239.8M
- IPO Year
- NLSP 2021
- OZ N/A
- Fundamental
- Price
- NLSP $2.31
- OZ $65.25
- Analyst Decision
- NLSP
- OZ
- Analyst Count
- NLSP 0
- OZ 0
- Target Price
- NLSP N/A
- OZ N/A
- AVG Volume (30 Days)
- NLSP 378.8K
- OZ 1.8K
- Earning Date
- NLSP 07-15-2025
- OZ 01-01-0001
- Dividend Yield
- NLSP N/A
- OZ N/A
- EPS Growth
- NLSP N/A
- OZ N/A
- EPS
- NLSP N/A
- OZ N/A
- Revenue
- NLSP N/A
- OZ $4,077,000.00
- Revenue This Year
- NLSP N/A
- OZ N/A
- Revenue Next Year
- NLSP N/A
- OZ N/A
- P/E Ratio
- NLSP N/A
- OZ N/A
- Revenue Growth
- NLSP N/A
- OZ 94.70
- 52 Week Low
- NLSP $1.30
- OZ $56.77
- 52 Week High
- NLSP $15.59
- OZ $82.89
- Technical
- Relative Strength Index (RSI)
- NLSP 48.87
- OZ 49.47
- Support Level
- NLSP $2.20
- OZ $64.39
- Resistance Level
- NLSP $3.08
- OZ $67.02
- Average True Range (ATR)
- NLSP 0.25
- OZ 0.81
- MACD
- NLSP -0.05
- OZ -0.11
- Stochastic Oscillator
- NLSP 16.36
- OZ 33.99
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.